LEUKINE
LEUKINE® (sargramostim) is the first and only FDA-approved GM-CSF that reduces the risk of infection-related outcomes after allogeneic and autologous BMT and improves survival after delayed or failed engraftment.1.
LEUKINE
Industry:
Biotechnology
Address:
Lynnwood, Washington, United States
Country:
United States
Website Url:
http://www.leukine.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Official Site Inspections
http://www.leukine.com Semrush global rank: 9.47 M Semrush visits lastest month: 152
- Host name: 38.127.92.75
- IP address: 38.127.92.75
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 